All who are involved in research, counseling, screening, diagnosis, treatment or prevention of hereditairy breast and ovarium cancer are welcome.
This year’s program will feature some extras: many years of collaboration of Hebon in IBCCS has resulted in some exciting findings on the impact of lifestyle and risk factors on risk assessment that will be presented by invited speakers from Great Britain , France and the USA. Two new related studies from Canada and the USA will also be presented.
3521 AL Utrecht
Do you have questions or comments, please contact:
Denise Jenner: firstname.lastname@example.org
Phone: 020 512 2484
RT @LudeFranke: Within Lifelines, a prospective population-based study of 167,000 Dutch people, we conduct COVID19 research with the aim to…